MOVING DAY 2016
I am participating in the Moving Day Tampa Bay walk benefiting the National Parkinson Foundation. It’s Saturday April 9, 2016 at the University of South Florida Marshall Center starting at 9:00 a.m.
The event will be for all ages and abilities. We will see a variety of movement activities, such as yoga, dance, Pilates, Tai Chi, stretching and much more before the walk. The purpose is to celebrate the importance of movement in our lives. My team is Rock Steady Boxing Tampa Bay.
I work out at Rock Steady at least three days a week. The program has made an enormous difference in my quality of life and sense of well-being. The program was funded in part by contributions to last year’s Moving Day.
Our team will demonstrate Rock Steady techniques at this year’s event.
Please consider being a part of my team or sponsoring me, and I encourage you to get your friends, family and coworkers involved. For more information visit
A SECOND TAMPA Y OFFERS INTENSIVE CYCLING FOR PARKIES
The Bob Sierra YMCA in Northdale is starting the Pedaling for Parkinson’s program, which is open to Parkinson’s patients and caregivers. It joins he South Tampa Family Y in offering the program. The Y is at 4029 Northdale Blvd. Phone number
You will need a medical release signed by your neurologist or primary car physician.
The classes are twice a week, on
Tuesdays and Thursdays at 11:00 AM and last for 1 hour.
It is free for the first 8 weeks. If you have Silver Sneakers the program is free after the eight weeks. Otherwise, a Y membership is required and covers the program’s cost.
I do the South Tampa program and find it highly effective in relieving PD symptoms. I do it in conjunction with Rock Steady Boxing in Largo.
Contrary to other reports, the New Tampa Y has no plans to start the cycling program.
PDF’s NICE TAKE ON EXERCISE BENEFITS
This piece is authoritative and worth your time reading.
GIL AND SHERRY HARDEN GET SELF-EFFICACIOUS (BUT IT COULD BE WORSE)
Sherry Harlan — longtime USF PD research associate and key member of Dr. Robert Hauser’s team—and I have been chosen to learn “self-efficacy” skills and apply them to the support of newly diagnosed Parkies.
The sponsoring organization is the Parkinson’s Disease Foundation. PDF discusses and defines self-efficacy:
“What happens when a person is diagnosed with Parkinson’s?
Many people are handed a diagnosis with very little guidance on what to do next.
“But the diagnosis is life changing. Facing life with a chronic progressive disease means facing changes to health, relationships, family life, employment and finances.
“Research tells us that when people are given the resources to cope with these changes, they are empowered to take an active role in managing PD, leading to better health and quality of life.
“PD SELF (Self-Efficacy Learning Forum) is an innovative disease management program that offers this approach. It was developed in 2013 by Diane Cook as part of a clinical trial sponsored by the Colorado Neurological Institute.
“Based on the psychosocial theory of self-efficacy, PD SELF helps people newly diagnosed with PD to create a personalized approach to managing their disease. Self-efficacy is the confidence a person has in his or her ability to influence an outcome or be successful in achieving a result.
“ Self-efficacy beliefs determine how people think, feel and motivate themselves. It is increasingly used in health care for its effectiveness in helping people to adopt healthier behaviors.
A central focus of PD SELF is to help people strengthen self-efficacy beliefs, thereby positively influencing the management of their disease. At the end of the first clinical trial testing this approach, researchers found that PD SELF:
Improved mental health and well-being of people
with PD and their care partners.
Decreased participants’ stress, anxiety and depression and improved sleep.
Improved participants’ emotional well-being, even when PD (or general health) declined.
Led to long-term improvement in the areas above, with changes observed for as long as one year after the clinical trial ended.
Led participants to become more active in the Parkinson’s community, for example through increased enrollment in clinical trials.”